Cargando…
Omitting transesophageal echocardiography before catheter ablation of atrial fibrillation or left sided atrial tachycardia in patients on oral anticoagulation
FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. INTRODUCTION: Catheter ablation (CA) is accepted as a safe and effective therapy for atrial Fibrillation AF and left sided atrial tachycardias (AT) and is a well-established standard of care. However, the procedure can lead to life-threatening...
Autores principales: | Maslova, V, Demming, T, Pantlik, R, Frank, D, Lyan, E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207431/ http://dx.doi.org/10.1093/europace/euad122.202 |
Ejemplares similares
-
Optimal anticoagulation intensity with warfarin for the prevention of thromboembolism with minimal bleeding in Asian patients with atrial fibrillation: multi-center, randomized controlled trial
por: Lee, K H, et al.
Publicado: (2023) -
Should we shift warfarin to non-vitamin K antagonist oral anticoagulants for patients with atrial fibrillation staying well on warfarin for years?
por: Chao, T, et al.
Publicado: (2023) -
The effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a Belgian nationwide cohort study
por: Grymonprez, M, et al.
Publicado: (2023) -
How good is time-in-therapeutic-range defined warfarin treatment compared to standard dose direct oral anticoagulants? Incidence of stroke in atrial fibrillation in a nationwide registry study
por: Lehto, M, et al.
Publicado: (2023) -
Racial differences in atrial fibrillation-related strokes and mortality
por: Kang, D S, et al.
Publicado: (2023)